Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection?
Description
Clostridioides difficile (C. difficile) is a gram-positive, toxin-forming, anaerobic bacillus, which is widely distributed in the intestinal tract of living organisms.1–3 The pathogenic properties are produced by toxins released into the
